Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Sell
76,578
-37,606
-33% -$727K 0.38% 103
2025
Q4
$1.87M Buy
114,184
+18,156
+19% +$320K 0.3% 123
2025
Q3
$1.8M Buy
96,028
+24,529
+34% +$440K 0.44% 81
2025
Q2
$1.44M Buy
+71,499
New +$1.24M 0.46% 80
2023
Q4
Sell
-9,608
Closed -$221K 472
2023
Q3
$221K Buy
+9,608
New +$241K 0.1% 222

Other funds holding XP

Neo Ivy Capital Management's XP Position: Q1 2026 in Review

Neo Ivy Capital Management reduced its XP (XP) stake by 33% in Q1 2026, selling an estimated $727K and leaving 76,578 shares worth $1.46M. The position accounts for 0.38% of the portfolio, ranked #103.

Neo Ivy Capital Management first reported a position in XP in Q3 2023 and has held it in 5 quarters since. The position peaked at $1.87M in Q4 2025. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Neo Ivy Capital Management held 76,578 shares of XP worth $1.46M as of Q1 2026.
  • Neo Ivy Capital Management sold 37,606 XP shares in Q1 2026, an estimated $727K.
  • XP made up 0.38% of Neo Ivy Capital Management's portfolio in Q1 2026, its #103 holding.
  • Neo Ivy Capital Management first reported a position in XP in Q3 2023 and has held it in 5 quarters since.
  • Neo Ivy Capital Management's XP position peaked at $1.87M in Q4 2025.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.